Suchen
Salarius Pharmaceuticals Ord Shs
DCOYZur Watchlist hinzufügen
3.100USD
+0.540+21.09%
Handelsschluss 09-22 16:00（ET）
1.64MMarktkapitalisierung
VerlustKGV TTM
Vorbörsliches Trading 07:20 (ET)4.460USD+1.360+43.87%
Vorbörsliches Trading 07:20 (ET)Über Unternehmen
Salarius Pharmaceuticals Ord Shs Profil
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -
Führungskräfte von Salarius Pharmaceuticals Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%
Mr. David J. Arthur
Mr. David J. Arthur
Director
Director
34.00
--
Mr. David J. Arthur
Mr. David J. Arthur
Director
Director
34.00
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Mark J. Rosenblum, CPA
Mr. Mark J. Rosenblum, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
11.36K
+85.21%
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Mr. Peter Marschel
Mr. Peter Marschel
Chief Business Officer
Chief Business Officer
3.90K
--
Ms. Tess Burleson
Ms. Tess Burleson
Independent Director
Independent Director
2.00K
+99.90%
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Independent Director
Independent Director
2.00K
+99.90%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Salarius Pharmaceuticals Ord Shs?
Die fünf größten Anteilseigner von Salarius Pharmaceuticals Ord Shs sind: Mr. Mark J. Rosenblum, CPA
Wie viele Institutionen halten Anteile an Salarius Pharmaceuticals Ord Shs (DCOY)?
Mit Stand vom 2026Q1 halten 24 Institutionen Anteile an Salarius Pharmaceuticals Ord Shs, mit einem Gesamtmarktwert von etwa 63.48K, was 11.93% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 34985.00 gestiegen.